Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Works by Ampudia-Blasco, F. Javier
Results: 17
1
2
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
3
Impact of High Intensity Interval Training Using Elastic Bands on Glycemic Control in Adults with Type 1 Diabetes: A Pilot Study.
- Published in:
- Applied Sciences (2076-3417), 2020, v. 10, n. 19, p. 6988, doi. 10.3390/app10196988
- By:
- Publication type:
- Article
4
A case of lipoatrophy with insulin glargine: long-acting insulin analogs are not exempt from this complication.
- Published in:
- 2005
- By:
- Publication type:
- journal article
5
A Case of Lipoatrophy With Insulin Glargine.
- Published in:
- 2005
- By:
- Publication type:
- Letter
6
A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?
- Published in:
- 2003
- By:
- Publication type:
- Case Study
7
Which people with diabetes are treated with a disposable, half‐unit insulin pen? A real‐world, retrospective, database study in Spain.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2023, v. 6, n. 6, p. 1, doi. 10.1002/edm2.451
- By:
- Publication type:
- Article
8
Impact of COVID‐19 lockdown on diabetes management and follow‐up in a broad population in Spain.
- Published in:
- European Journal of Clinical Investigation, 2022, v. 52, n. 6, p. 1, doi. 10.1111/eci.13771
- By:
- Publication type:
- Article
9
Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain.
- Published in:
- PharmacoEconomics, 2006, p. 49, doi. 10.2165/00019053-200624001-00005
- By:
- Publication type:
- Article
10
Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.
- Published in:
- 2006
- By:
- Publication type:
- journal article
11
Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009–2014.
- Published in:
- Human Vaccines & Immunotherapeutics, 2017, v. 13, n. 11, p. 2606, doi. 10.1080/21645515.2017.1368600
- By:
- Publication type:
- Article
12
Usefulness of the CDC/AAP and the EFP/AAP Criteria to Detect Subclinical Atherosclerosis in Subjects with Diabetes and Severe Periodontal Disease.
- Published in:
- Diagnostics (2075-4418), 2025, v. 15, n. 7, p. 928, doi. 10.3390/diagnostics15070928
- By:
- Publication type:
- Article
13
Patient‐reported outcomes in adults with type 1 diabetes in global real‐world clinical practice: The SAGE study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1892, doi. 10.1111/dom.14416
- By:
- Publication type:
- Article
14
Propensity‐score‐matched comparative analyses of simultaneously administered fixed‐ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2821, doi. 10.1111/dom.13462
- By:
- Publication type:
- Article
15
Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 448, doi. 10.1111/dom.13071
- By:
- Publication type:
- Article
16
Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide ( iGlarLixi) vs insulin glargine and lixisenatide monocomponents
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1798, doi. 10.1111/dom.12980
- By:
- Publication type:
- Article
17
Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 4, p. 723, doi. 10.1007/s13300-023-01382-9
- By:
- Publication type:
- Article